Mankind Pharma: This pharma stock has potential to double your money in 3-4 years - Check Anil Singhvi's View

Mankind Pharma Share Price Target: The market has been quite volatile for the past few days, and benchmark equity indices tanked in early trade on Friday. The 30-share BSE Sensex tanked 413.36 points to 72,227.83. The NSE Nifty skidded 86.8 points to 21,925.15. Amid this, there is a good opportunity for investors to create wealth in the long run. If you are looking for one such stock, here's one picked by Zee Business Managing Editor Anil Singhvi.

Mankind Pharma Share Price Target: Anil Singhvi's View

Mankind Pharma is today's 'Wealth Creation Pick' by market wizard Anil Singhvi. This stock has strong fundamentals and can give strong returns in the long term. In the last 6 months, this stock has given around 25 per cent return.

Singhvi said that Mankind Pharma is a pharma-cum-FMCG company and has strong promoters. 

"Ahuja family is quite old in this business and they have good hold. It is one of the largest pharma companies in the domestic market. The company's domestic pharma business is bigger than Sun Pharma. The good thing is that the company gets about 97 per cent of its business from India. Therefore it is not concerned about things related to USFDA. Being a domestic business, they do not have legal expenses at the international level. Generally, R&D and litigation (legal) are two big expenses for pharma companies," he said.

Anil Singhvi said that Mankind Pharma has a stronghold in the pharma market as they have around 40 brands, many of which are market leaders. 

"Their dealer network is also strong. Based on the data of September 2023 and December 2023, the share from both DII and FII has increased. This is a good sign. The past financial track record of the company has been strong. For the last 5 years, revenue growth has been increasing at the rate of 16 per cent and profit at 12 per cent year after year," he added.

Mankind Pharma Share Price Target By Anil Singhvi

Singhvi said this stock can double investors' money in 3-4 years with a growth of 20-25 per cent. The short-term target for Mankind Pharma is Rs 2700. The medium-term target is Rs 3300 and the long-term target is Rs 4000. 

He advised investors to do an SIP in this stock on every 10 per cent fall.  

Mankind Pharma Share Price History

Mankind Pharma's stock has seen a good rise in the last six years. The stock's return in 6 months has been around 25 per cent. There is an increase of 12 per cent in the stock in three months. It has jumped about 10 per cent so far this year.